Replay available

Medtronic plc (MDT) Q4 2025 Earnings Call

Medtronic plc (NYSE: MDT) Q4 2025 earnings conference call, held 2025-05-21. Replay captured from the company's public earnings webcast.

Wed, May 21, 2025 at 8:00 AMendedReplay
Medtronic plc (MDT) Q4 2025 Earnings Call

Investor webinar replay

Latest news releases

Companies on this event

Featured Presenters

Ryan Weisfenning

Vice President and Head of Medtronic Investor Relations

Jeff Martha

Chairman and Chief Executive Officer

Q Dallara

EVP and President of Diabetes

Thierry Piatone

Chief Financial Officer

Unidentified Participant

Participant

Danielle Antalfi

Analyst at UBS

Matt Mixick

Analyst at Barclays

Robbie Marcus

Analyst at J.P. Morgan

Larry Bagelson

Analyst at Wells Fargo

Matt Taylor

Analyst at Jefferies

Brett Wall

EVP and President of Neuroscience Portfolio

Sean Salmon

EVP and President of the Cardiovascular Portfolio

Shagan Singh

Analyst at ABC

Replay transcript excerpt

Good morning. I'm Ryan Weisfenning, Vice President and Head of Medtronic Investor Relations. And I appreciate that you're joining us for our fiscal 25 fourth quarter video earnings webcast. Before we go inside to hear our prepared remarks, I'll share a few details about today's webcast. Joining me are Jeff Martha, Chairman and Chief Executive Officer, and Thierry Piatone, Chief Financial Officer. Jeff and Thierry will provide comments on the results of our fourth quarter, which ended on April 25th, 2025, and our outlook for fiscal year 26. After our prepared remarks, the executive VPs from each of our four segments will join us and we'll take questions from the sell side analysts that cover the company. Today's program should last between 60 and 90 minutes. Earlier this morning, we issued a press release containing our financial statements, divisional and geographic revenue summaries, and non-GAAP reconciliations. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press release or on our website at investorrelations.medtronic.com. During today's program, many of the statements we make may be considered forward-looking statements, and actual results may differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause our actual results to differ is contained with our periodic reports and other filings that we make with the SEC, and we do not undertake to update any forward-looking statement. Unless we say otherwise, all comparisons are on a year-over-year basis, and revenue comparisons are made on an organic basis, which excludes the impact of foreign currency and fourth quarter revenue in the current and prior y...

More from Medtronic Plc.